| Company/Division name | Cascade Chemistry |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2022 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 14 |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | active pharmaceutical ingredients |
| What domestic positive factors made reshoring more attractive? | Higher productivity, Under-utilized capacity, Other, import replacement |
